On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))

Farci, PatriziaMarcellin, PatrickLu, Zhi-MengDiago, MoisesLai, Ming-YangKittis, GYurdaydin, CihanZahm, FEBonino, FD2021-08-192021-08-192005-04Farci, P. vd. (2005). "On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))". Journal of Hepatology, 42, 175-175.0168-8278http://hdl.handle.net/11452/21473Bu çalışma, 13-17 Nisan 2005 tarihleri arasında Paris'te düzenlenen Avrupa Karaciğer Çalışmaları 40. Toplantısında bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyOn-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))Meeting Abstract00022902400048517517542Gastroenterology & hepatology